3. OUTCOME AND FOLLOW-UP
After emergency surgery, the patient recovered uneventfully. He was
referred to the medical oncology team for further appropriate
postoperative management. Subsequently, he received standard
chemotherapeutic regimens (called Rituximab-CHOP) scheduled was
administrated. Unfortunately, the patient sustained acute critical
conditions presented hemodynamic worsen gradually, congestive heart
failure, complicated hospital bacterial infection, massive pleural
effusion with acute respiratory failure and hypovolemic shock related
acute kidney failure developed. The patient expired six months after
surgery.